USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Global Cancer Therapeutics Market Outlook
28-Oct-2005
Global
Market Research
F404-01-00-00-00
HC01452-GL-MR_05946
The Global Cancer Therapeutics Market is a fast growing market that is relying heavily on new drugs. The total therapeutic market is expected to grow from $23.1 billion in 2004 to $60.6 billion in 2011. The targeted therapy segment is providing the growth of the entire market with an expected compound annual growth rate of 24.1 percent for 2004-2011.
Introduction
- Introduction
- Disclaimer
- Certification
- Contents
- Top 15 Growth Cancer Therapeutics
Market Overview
- Contents
- Research Scope and Methodology
- Abreviations
- Segmentation
- Targeted Therapy Segments
- Targeted Therapy Definitions
- Summary of Findings
- Market Drivers (1)
- Market Drivers (2)
- Challenges and Strategies (1)
- Challenges and Strategies (2)
- Challenges and Strategies (3)
- Challenges and Strategies (4)
- Challenges and Strategies (5)
Total Market Forecasts
- Contents
- Total Market Forecasts
- Total Market Forecasts by Therapeutic Class
- US Forecasts by Therapeutic Class
- Ex US Forecasts by Therapeutic Class
- Cytotoxic Therapy Forecasts
- Hormone Therapy Forecasts
- Targeted Therapy Forecasts
- Global Market Share Analysis
- US Market Share Analysis
- Ex US Market Share Analysis
NSCLC
- Contents
- Disease Overview
- Epidemiology Trends
- Incidence
- Mortality
- Treatment Overview
- Common Drugs
- Common Regimens
- Treatment Diagram
- Revenue Forecasts
- Drug Development
Breast Cancer
- Contents
- Disease Overview
- Epidemiology
- Incidence
- Mortality
- Treatment Overview
- Common Drugs
- Common Regimens
- Hormone Treatment Diagram
- Metastatic Treatment Diagram
- Revenue Forecasts
- Drug Development
Colorectal Cancer
- Contents
- Disease Overview
- Epidemiology
- Incidence
- Mortality
- Treatment Overview
- Common Drugs
- Common Regimens
- Treatment Diagram
- Revenue Forecasts
- Drug Development
Prostate Cancer
- Contents
- Disease Overview
- Epidemiology
- Incidence
- Mortality
- Treatment Overview
- Common Drugs
- Common Regimens
- Treatment Diagram
- Revenue Forecasts
- Drug Development
Top 15 Growth Therapeutic Cancer Drugs (Overview; Indications Development and Forecasts)
- Contents
- Top 15 Growth Therapeutic Cancer Drugs
- Rituxan/MabThera
- Taxotere
- Gleevec/Glivec
- Eloxatin
- Gemzar
- Herceptin
- Zometa
- Casodex
- Arimidex
- Avastin
- Camptosar/Campto
- Temodar/Temodal
- Xeloda
- Femara
- Erbitux
Recent Filings and Approvals
- Contents
- Recent Filings and Approvals
Key Late-Stage Pipeline Drugs
- Contents
- Key Late-Stage Pipeline Drugs
Awards
- Contents
- Frost & Sullivan Awards
- Company of the Year
- Product Innovation of the Year
- Product-Line/Pipeline Strategy of the Year
- Entrepreneurial Company of the Year
- Business Development Strategy of the Year
Frost & Sullivan Capabilities
- Contents
- Our Capabilities I
- Our Capabilities II
- Our Consulting Clients
- Growth Consulting
- Growth Consulting Process
- Growth Consulting Deliverables
- Growth Partnership Service
- Growth Partnership Services Platform
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
16 Oct 2026 | Global | Market Research
Public Sector Healthcare Cloud Market, North America and Europe, 2026
Public healthcare organizations across North America and Europe are using cloud technologies to support modernization efforts that extend beyond infrastructure replacement. Cloud is increasingly being adopted to improve interoperability, enable secure data sharing, support analytics and AI initiativ...
16 Oct 2026 | Global | Technology Research
Innovations and Growth Opportunities in Precision Therapeutics, AI-Enabled Discovery and Bioengineering, Regenerative Medicine, and Next-Generation Vaccine Platforms
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations transforming precision therapeutics, regenerative medicine, AI-enabled discovery, laboratory automation, targeted delivery, vaccines, and biomanufactu...
15 Oct 2026 | Global | Frost Radar
Frost Radar™: US and European Mammalian Contract Development and Manufacturing Organizations, 2026
The US and European mammalian contract development and manufacturing organization (CDMO) market is entering a new phase of strategic evolution, driven by accelerating biologics outsourcing, increasing molecule complexity, and growing demand for resilient, end-to-end manufacturing partnerships. As mo...
08 Oct 2026 | Global | Frost Radar
Frost Radar: Endoscopy Device Technology Ecosystem, 2026
The endoscopy device market is advancing toward higher-quality visualization and improved clinical decision-making, with innovation across 4K ultrahigh-definition display systems, image-enhanced endoscopy, and computer-aided detection systems. Advanced visualization is evolving through improvements ...
07 Oct 2026 | Global | Technology Research
Growth Opportunities in Image-Guided Cancer Ablation Systems
Image-guided cancer ablation systems are minimally invasive medical technologies that use real-time imaging to accurately guide the placement of an ablation device into a tumor, enabling localized destruction of cancerous tissue while minimizing damage to surrounding healthy structures.The increasin...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.